Kristina Torfgard (IRLAB Therapeutics)2024-09-05T10:00:08
Introducing Kristina Torfgard! Holding a PhD in Clinical Pharmacology, she has over 30 years’ experience in drug development and is currently CEO of IRLAB Therapeutics.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-08-20T08:43:00Z
Author Dr Daniel Tillett
2026-08-11T07:02:00Z
Contributor Professor Joseph C. Wu, Drug Target Review
2026-07-23T06:20:00
Contributor Laura Lotfi, Drug Target Review
2026-09-23T15:00:00
Sponsored by BioIVT
2026-03-25T15:00:00
Sponsored by Yokogawa
2025-05-28T14:00:00
Sponsored by Eurofins DiscoverX
2023-12-11T10:49:07
Sponsored by Leica Microsystems
2023-03-28T11:38:32
Sponsored by Bio-Techne
Site powered by Webvision Cloud